Mr. Sze is a Director of Axis Therapeutics. He is also the Chief Financial Officer of Athenex, leading corporate finance, accounting and IR matters. Mr. Sze joined Athenex in 2017 after more than ten years in the investment banking industry. He was previously with Credit Suisse’s Investment Banking and Capital Markets division, advising companies and their senior management on capital markets, mergers and acquisitions, and other financing and strategic transactions. While at Credit Suisse, Mr. Sze led the execution of the initial public offering of Athenex. Randoll graduated with a B.S. in Chemical Engineering from University of California at Berkeley, and a M.S. in Operations Research from Columbia University.